UiPath (PATH) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

UiPath could become the connective tissue linking the software sprawl that companies face. AI is helping UiPath expand the boundaries of traditional robotic process automation. Its focus on secure, ...

Small- and mid-cap AI plays - PATH, FIVN, QLYS, TDC and BB lagged last year but could become game changers in 2026 as AI infrastructure demand stays bullish.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

UiPath presents a compelling accumulation opportunity after recent profit-taking, with core RPA business strength and visible AI-driven growth catalysts. PATH's revenue growth has stabilized at double ...

A rush of agentic AI solutions is hitting the enterprise market, and now one of the bigger players in automation has scooped up a startup in the space in hopes of taking a bigger piece of that market.

I recommend rotating into catalyst-driven small- and mid-cap stocks like UiPath to protect capital as the S&P 500 hits new highs. UiPath stands out with improving sales momentum, profitability, and a ...

UiPath, Inc. (NYSE: PATH), a global leader in agentic automation, today announced that Ashim Gupta, Chief Operating Officer and Chief Financial Officer, will participate in a fireside chat at the 28th ...

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, December 31st: Ulta ...

Omega Healthcare partnered with UiPath to automate medical billing and other administrative tasks. The revenue cycle management company has saved employees hours with its AI document-processing tool.